Village Farms International (VFF) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
11 May, 2026Executive summary
Achieved consolidated net sales of $50.2 million for Q1 2026, up 27% year-over-year, driven by a 171% increase in international cannabis exports and continued Canadian market leadership.
Adjusted EBITDA from continuing operations increased 118% to $9.9 million, representing 20% of sales.
Net income attributable to shareholders was $2.9 million, or $0.03 per share, compared to a net loss of $6.7 million in Q1 2025.
Facility upgrades in British Columbia expanded EU GMP-compliant production capacity, now operating the world’s largest such facility.
The company realigned to a single Cannabis segment, consolidating all operations for efficiency.
Financial highlights
Consolidated net sales rose 27% year-over-year to $50.2 million in Q1 2026.
Gross margin improved to 43% from 39% in Q1 2025, exceeding the targeted 30%-40% range.
Net income from continuing operations improved to $2.9 million, reversing a $2.1 million loss in Q1 2025.
Adjusted EBITDA increased 118% year-over-year to $9.9 million, with a margin of 20%.
Cash and cash equivalents at quarter-end: $50.5 million.
Outlook and guidance
Expects continued profitable growth for the remainder of 2026 and through 2027.
Delta 2 greenhouse expansion in Canada to add 40 metric tonnes of annualized production by 2027.
Netherlands Phase II facility to ramp up to 10 metric tonnes annually by year-end 2026.
Confident in stable pricing for EU GMP-compliant products, especially in Germany.
Anticipates benefiting from U.S. regulatory changes following the executive order to reschedule marijuana.
Latest events from Village Farms International
- Record profitability, 70% cannabis sales growth, and strong cash flow drive future expansion.VFF
Q4 20252 May 2026 - Shareholders to vote on directors, executive pay, and auditor at the June 2026 virtual meeting.VFF
Proxy filing1 May 2026 - Annual meeting to elect directors, approve pay, and appoint auditor, with strong governance focus.VFF
Proxy filing29 Apr 2026 - Major joint venture, global cannabis growth, and strong 2025 financials drive future expansion.VFF
Corporate presentation28 Apr 2026 - All director nominees and motions were approved, with final results to be published.VFF
AGM 20243 Feb 2026 - Record sales growth in Canadian cannabis and produce, but net loss widened by U.S. impairment.VFF
Q2 20242 Feb 2026 - Q3 sales up 20%, driven by Canadian cannabis, fresh produce, and international growth.VFF
Q3 202416 Jan 2026 - All director nominees and motions were approved, with final results to be published.VFF
AGM 20256 Jan 2026 - Full-year sales up 18% to CAD 336M; international medicinal sales to triple in 2025.VFF
Q4 202425 Dec 2025